Renid chewable tablets with mint flavor No. 24

Instructions for Renid chewable tablets with mint flavor No. 24

Composition

Composition per 1 chewable tablet: 1 tablet contains calcium carbonate - 680 mg (mg), magnesium carbonate - 80 mg (mg).

Excipients: sweetener sorbitol; stabilizer corn starch; diluent potato starch; anti-caking agents talc, magnesium stearate; mint flavoring; sweetener sucralose (sucralose); anti-caking agent silicon dioxide. GMO-free.

Recommendations for use

It can be recommended as a source of calcium and magnesium, which contributes to:

• reducing the acidity of gastric juice by neutralizing stomach acid;
• reducing the unpleasant feeling of heartburn.

Before use, consultation with a doctor is necessary.

Warning

Do not exceed the recommended daily intake (serving). Do not use as a substitute for a balanced diet.

Contraindication

Individual sensitivity to components, children under 15 years of age, pregnancy and lactation in women, fructose intolerance, conditions accompanied by kidney disease, nephrolithiasis, hypercalciuria, hypercalcemia, severe diarrhea, myasthenia gravis.

Method of administration and doses

Adults and children over 15 years of age should take 2 tablets once a day. Chew the tablet well or keep it in your mouth until it dissolves completely; do not swallow it whole.

Release form

12 chewable tablets in a blister, 2 blisters in a cardboard box.

Net weight of 1 chewable tablet: 1140 mg (mg) ± 5%.

Storage conditions

In the manufacturer's original packaging in a dry, dark place at a temperature not exceeding 25 °C. 3Keep out of the reach of children.

Expiration date

3 years.

Not a medicine. Dietary supplement.

Producer

Ananta Medicare Limited, registered address: 621, Ring Road Mall, Sector-3, Rohini, New Delhi - 110085, India, tel. + 91 1147050531.

Actual address of the manufacturing facility: J-1-265, Phase - II, RIKO Industrial Area, Udyog Vihar, Sriganganagar (Raj.), India.

Importer: TOB "Ananta Medicare Ukraine", 61001, Ukraine, Kharkiv, 37 Iskrynska St., tel. +38 (057) 739-03-09.